Diagnostic Centers of America is the First in South Florida to Offer New, More Comfortable Mammogram

DELRAY BEACH, Fla., May 15, 2018 (Newswire.com) - Diagnostic Centers of America is the first in South Florida to offer new, more comfortable mammogram. The newly acquired SmartCurve™ breast stabilization system improves patient comfort without compromising image quality, workflow, or dose.

Diagnostic Centers of America (DCA) is the first in South Florida to offer the SmartCurve™ breast stabilization system, which is clinically proven to deliver a more comfortable mammogram without compromising image quality, workflow or dose.[i] This latest innovation is part of DCA’s ongoing commitment to superior breast cancer detection and has the potential to increase screening volume and compliance for the countless women who have reported avoiding regular mammograms due in large part to the fear of discomfort associated with breast compression.

With this new technology, we are not only able to provide a more comfortable mammogram but can do so while maintaining clinical accuracy, which is key. Mammograms play such a critical role in the early detection of breast cancer and we're hopeful that with the addition of the SmartCurve system, we'll be able to lessen the pain and anxiety associated with mammograms and, as a result, increase screening compliance.

Steven J. Shullman, CEO / President, DCA

The SmartCurve system is available exclusively with Hologic’s Genius^TM 3D Mammography^TM exam, which is currently in use by DCA and detects more invasive cancers, reduces false positives, and is FDA approved as superior to conventional 2D mammography for all women, including those with dense breasts.[ii],[iii],[iv]

“With this new technology, we are not only able to provide a more comfortable mammogram, but can do so while maintaining clinical accuracy, which is key,” said Steven J. Shullman, CEO and President of DCA. “Mammograms play such a critical role in the early detection of breast cancer and we’re hopeful that with the addition of the SmartCurve system, we’ll be able to lessen the pain and anxiety associated with mammograms and, as a result, increase screening compliance.”

The SmartCurve system features a proprietary curved surface that mirrors the shape of a woman’s breast to reduce pinching and allow better distribution of force over the entire breast. In a recent clinical study comparing the SmartCurve breast stabilization system to traditional flat paddle compression, the SmartCurve system improved comfort in 93 percent of women who reported moderate to severe discomfort with standard compression.¹ In addition, 95 percent of those surveyed would recommend facilities that use the system.¹

“We’re excited to provide this first-of-its-kind technology to our patients and remain committed to offering the women of our community the best breast care possible,” added Steven J. Shullman.

 The Genius^TM 3D Mammography^TM exam is only available on a Hologic® 3D Mammography™ system. The exam consists of a 2D and 3D™ image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D™ image set. There are more than 4,000 Hologic 3D Mammography™ systems in use in the U.S., so women have convenient access to the Genius exam. To learn more about the Genius exam, visit http://www.Genius3DNearMe.com.

For more information about DCA and its breast health services, visit www.dcamedical.com.

About Diagnostic Centers of America

Now celebrating its 25-year anniversary, Diagnostic Centers of America is a nationally recognized, outpatient radiology services provider headquartered in Delray Beach, FL. With five locations in Palm Beach County, DCA offers patients a full array of diagnostic imaging services including MRI, CT, Nuclear Medicine, PET/CT, 3D Mammography, Bone Densitometry, and X-ray.

About Hologic

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment.  For more information on Hologic, visit www.hologic.com.

Hologic, SmartCurve, Genius, 3D and 3D Mammography and associated logos are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.

[i] Smith, A. Improving Patient Comfort in Mammography. Hologic WP-00119 Rev 003 (2017).

[ii] Results from Friedewald, SM, et al. "Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia® Dimensions ® on screening outcomes. Individual results may vary. The study found an average 41% (95% CI: 20-65%) increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3DÔ mammograms acquired with the Hologic 3D MammographyÔ system versus women receiving 2D FFDM mammograms only.

[iii] Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.

[iv] U.S. Food & Drug Administration Premarket Approval (PMA).  FDA.gov https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P080003 accessed June 5, 2017.

Media Contact: Lynne Marlette, Marketing Manager
561-994-8600 | [email protected]

Source: Diagnostic Centers of America